Who owns ARTIVA BIOTHERAPEUTICS INC?
- Ticker: ARTV
- CUSIP Number: 04317a107
Tip: Access positions for across all investors
Analyze quarterly positions in Artiva Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Artiva Biotherapeutics stock
Who bought or sold ARTIVA BIOTHERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 9.9M | $28M | 0% | Sep 2025 |
|
| 5AM Venture Management | 2.4M | $10M | 0% | Dec 2025 |
|
| VR Adviser | 1.6M | $6.9M | 0% | Dec 2025 |
|
| Citadel Advisors | 798k | $2.3M | 419% | Sep 2025 |
|
| venBio Partners | 649k | $2.8M | -44% | Dec 2025 |
|
| Franklin Resources | 520k | $2.2M | 0% | Dec 2025 |
|
| Revelation Capital Management | 299k | $1.3M | 100% | Dec 2025 |
|
| Millennium Management | 262k | $752k | -20% | Sep 2025 |
|
| Vanguard Group | 246k | $1.1M | 55% | Dec 2025 |
|
| BlackRock | 213k | $912k | -28% | Dec 2025 |
|
| Wellington Management Company | 194k | $557k | 0% | Sep 2025 |
|
| Renaissance Technologies | 116k | $499k | 47% | Dec 2025 |
|
| Geode Capital Management | 101k | $434k | -9% | Dec 2025 |
|
| Alyeska Investment Group | 100k | $429k | 0% | Dec 2025 |
|
| Marshall Wace | 80k | $341k | 100% | Dec 2025 |
|
| Jane Street | 41k | $175k | 100% | Dec 2025 |
|
| UBS Group | 37k | $158k | 74% | Dec 2025 |
|
| State Street Corporation | 36k | $154k | -40% | Dec 2025 |
|
| Bridgeway Capital Management | 35k | $101k | 0% | Sep 2025 |
|
| Scientech Research | 28k | $119k | 100% | Dec 2025 |
|
| OMERS Administration Corporation | 21k | $91k | 100% | Dec 2025 |
|
| Two Sigma Investments | 20k | $58k | -5% | Sep 2025 |
|
| Springbok Capital Management | 14k | $41k | 100% | Sep 2025 |
|
| Goldman Sachs Group | 12k | $52k | -76% | Dec 2025 |
|
| Russell Investments | 5.5k | $24k | 0% | Dec 2025 |
|
| FMR | 4.9k | $14k | -88% | Sep 2025 |
|
| Jpmorgan Chase & Co | 4.0k | $12k | 100% | Sep 2025 |
|
| Wells Fargo & Company | 1.5k | $6.4k | -12% | Dec 2025 |
|
| Tower Research Capital | 1.1k | $4.7k | -89% | Dec 2025 |
|
| Royal Bank of Canada | 840.00 | $2.7k | -25% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 542.00 | $2.3k | -100% | Dec 2025 |
|
| Mark Sheptoff Financial Planning | 400.00 | $1.7k | 0% | Dec 2025 |
|
| Advisor Group Holdings | 32.00 | $136.998400 | 100% | Dec 2025 |
|
Who sold out of Artiva Biotherapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| XTX Topco | Sep 2025 | 48k | $138k |
| Landscape Capital Management | Sep 2025 | 39k | $112k |
| Hrt Financial | Sep 2025 | 27k | $77k |
| Qube Research & Technologies | Sep 2025 | 26k | $73k |
| Barclays | Sep 2025 | 13k | $36k |
| China Universal Asset Management | Sep 2025 | 4.3k | $12k |
| Mirae Asset Global Investments | Sep 2025 | 944.00 | $2.7k |
| Gf Fund Management | Sep 2025 | 510.00 | $1.5k |
| EverSource Wealth Advisors | Sep 2025 | 159.00 | $455.996100 |